All Stories

  1. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
  2. Basal and IL-1β enhanced chondrocyte chemotactic activity on monocytes are co-dependent on both IKKα and IKKβ NF-κB activating kinases
  3. Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction
  4. HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis
  5. Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland
  6. B cell zone reticular cell microenvironments shape CXCL13 gradient formation
  7. ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins
  8. Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex
  9. Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration
  10. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity
  11. Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis
  12. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis
  13. Insight on the regulation of chemokine activities
  14. Molecular Signatures of Immunity and Immunogenicity in Infection and Vaccination
  15. Chemokine activity modulation
  16. Editorial: Regulation of Inflammation, Its Resolution and Therapeutic Targeting
  17. Macrophage Death following Influenza Vaccination Initiates the Inflammatory Response that Promotes Dendritic Cell Function in the Draining Lymph Node
  18. Impairment of CCR6 + and CXCR3 + Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization
  19. Modulation of Chemokine Responses: Synergy and Cooperativity
  20. Potential of PEGylated Toll-Like Receptor 7 Ligands for Controlling Inflammation and Functional Changes in Mouse Models of Asthma and Silicosis
  21. Function of Chemokines and Their Receptors in Immunity
  22. Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking
  23. Immune Cells, Recruitment and Localization of
  24. Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis
  25. HMGB1 and leukocyte migration during trauma and sterile inflammation
  26. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
  27. Chemokines in immunopathology: From dark sides to clinical translation
  28. Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response
  29. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases
  30. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
  31. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells
  32. Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
  33. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes
  34. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint
  35. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma
  36. Lymphocyte homing and immunology of extranodal lymphoid tissues
  37. The central nervous system in mucosal vaccination of rhesus macaques with simian immunodeficiency virus Δnef
  38. CCL21 Expression Pattern of Human Secondary Lymphoid Organ Stroma Is Conserved in Inflammatory Lesions with Lymphoid Neogenesis
  39. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum
  40. CD molecules 2005: human cell differentiation molecules
  41. Systematic microanatomical analysis of CXCL13 and CCL21in situ production and progressive lymphoid organization in rheumatoid synovitis
  42. A rich chemokine environment strongly enhances leukocyte migration and activities
  43. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first ?-strand of chemokine
  44. Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines
  45. I-TAC/CXCL11 is a natural antagonist for CCR5
  46. Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5
  47. CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue
  48. Secondary Lymphoid Tissue Chemokine (CCL21) Is Upregulated in Allergic Contact Dermatitis
  49. A role for chemokines in the induction of chondrocyte phenotype modulation
  50. Regulation of Dendritic Cell Migration to the Draining Lymph Node
  51. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes
  52. Expression of CS-1 fibronectin precedes monocyte chemoattractant protein-1 production during elicitation of allergic contact dermatitis
  53. Chronic ‘Immunological’ Rhinosinusitis: General Aspects, Cytokines, Chemokines and Possible Therapeutic Consequences
  54. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells
  55. Expression of B-cell–attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma
  56. Growth-related oncogene ? induction of apoptosis in osteoarthritis chondrocytes
  57. CD antigens 2002
  58. CD Antigens 2001
  59. CD antigens 2001
  60. CD Antigens 2001: Aims and Results of HLDA Workshops
  61. CD antigens 2001
  62. CD antigens 2001
  63. CD antigens 2001
  64. CD Antigens 2001
  65. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
  66. CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease
  67. Cell cycle–dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity
  68. Macrophages infiltrating the tissue in chronic pancreatitis express the chemokine receptor CCR5
  69. Chemokine expression in pouchitis
  70. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines
  71. MCP-3 in inflammatory bowel disease Reply
  72. Chemokine expression in pouchitis
  73. CXC and CC chemokine expression in inflamed and non-inflamed pelvic ileal pouch tissue
  74. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation
  75. BCA-1 is highly expressed in Helicobacter pylori–induced mucosa-associated lymphoid tissue and gastric lymphoma
  76. Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis
  77. Enhanced Expression of Eotaxin and CCR3 in Atopic Dermatitis
  78. Chemokines and chemokine receptors in allergic diseases
  79. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis
  80. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis
  81. CXC and CC chemokine expression in ulcerative colitis
  82. Chemokine Expression in Heart Transplantation
  83. Chemokines and Chemokine Receptors in Allergic Inflammation
  84. CCR5 is characteristic of Th1 lymphocytes
  85. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils
  86. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
  87. Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes
  88. CKβ8, a novel CC chemokine that predominantly acts on monocytes
  89. Synovial expression of cell adhesion molecules in polymyalgia rheumatica
  90. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment
  91. RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors
  92. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin
  93. Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant.
  94. HCC-1, a novel chemokine from human plasma.
  95. PI 3-Kinase-Dependent and Independent Chemotaxis of Human Neutrophil Leukocytes
  96. Endothelin-1 in idiopathic pulmonary fibrosis.
  97. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes
  98. Cytokine Production in Felty’s Syndrome
  99. IL-8 Concentration in β-Thalassaemia and After Bone Marrow Transplantation
  100. Serum markers of immune activation and liver allograft rejection
  101. Intracellular nucleotides of lymphocytes and granulocytes from normal ageing subjects
  102. Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.
  103. T-CELL RECEPTOR GAMMA-DELTA POSITIVE LYMPHOCYTES IN SYNOVIAL MEMBRANE
  104. Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation.
  105. Natural chemokine antagonism and synergism